therapeutics
UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome
There are currently no approved cures for Fragile X syndrome — the most common cause of inherited intellectual disability. At the moment, the treatments are designed to manage symptoms, from…
How four-person startup Luminopia is using TV to treat lazy eye
If you’re diagnosed with lazy eye — otherwise known as amblyopia — as a child, there are only a few options at your disposal. You can wear an eye patch,…
Breakout ‘CRISPR platform’ company Mammoth Biosciences is officially a unicorn
The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says. The billion-dollar valuation comes on the back of a $150 million Series D round led by Redmile…
Digital therapy program for fibromyalgia receives FDA breakthrough device designation
Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12-week smartphone-assisted fibromyalgia management program. This is the company’s first breakthrough designation, and precedes a…
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on Friday. According to S-1 filings, shares were estimated to price between $14 and $16…
Absci Corp., a Vancouver company behind a multifaceted drug development platform, went public on Thursday. It’s another sign of snowballing interest in new approaches to drug development — a traditionally…
“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugs
On Monday, a 17-year drought in the world of Alzheimer’s drugs ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy behind the FDA’s decision was considerable, but it…
